Post-hoc analysis on the CD14 C(-260)T promoter polymorphism and coronary heart disease

Physiological Research

Volumn 56, Issue 6, 2007, Pages 727-733

  Porsch Ozcurumez M ^a   Hucke, J ^b   Westphal, S ^b   Hubacek J A ^a,c,d   Schmitz, G ^a   Luley, C ^b  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b OTTO VON GUERICKE UNIVERSITY   (Germany)

^c INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

^d Center for Cardiovascular Research   (Czech Republic)

Author keywords

Atherosclerosis; CD14; Genetics; Inflammation

Indexed keywords

BIOLOGICAL MARKER; CD14 ANTIGEN; DNA; LIPID;

AGED; ARTICLE; BIOSYNTHESIS; BLOOD; CORONARY ARTERY DISEASE; FEMALE; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; HUMAN; MALE; MIDDLE AGED; PROMOTER REGION; RISK; STATISTICAL MODEL;

AGED; ANTIGENS, CD14; BIOLOGICAL MARKERS; CORONARY DISEASE; DNA; FEMALE; GENETICS; GENOTYPE; HUMANS; LIPIDS; LOGISTIC MODELS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); RISK;

EID: 41749110953     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. BALDINI M, LOHMAN IC, HALONEN M, ERICKSON RP, HOLT PG, MARTINEZ FD: A polymorphism* in the 5′ flanking region of the CD14 gene is associated with circulating soluble CD14 levels and with total serum immunoglobulin E. Am J Respir Cell Mol Biol 20: 976-983, 1999.
2. CHAO YC, CHU HC, CHANG WK, HUANG HH, HSIEH TY: CD14 promoter polymorphism in Chinese alcoholic patients with cirrhosis of liver and acute pancreatitis. World J Gastroenterol 11: 6043-6048, 2005.
3. EILERTSEN KE, OLSEN JO, BROX J, ØSTERUD B: Association of the -159C→T polymorphism in the CD14 promoter with variations in serum lipoproteins in healthy subjects. Blood Coagul Fibrinolysis 14: 663-670, 2003.
4. ELGHANNAM H, TAVACKOLI S, FERLIC L, GOTTO AM JR, BALLANTYNE CM, MARIAN AJ: A prospective study of genetic markers of susceptibility to infection and inflammation, and the severity, progression, and regression of coronary atherosclerosis and its response to therapy. J Mol Med 78: 562-568, 2000.
5. ENG HL, WANG CH, CHEN CH, CHOU MH, CHENG CT, LIN TM: A CD14 promoter polymorphism is associated with CD14 expression and Chlamydia-stimulated TNF alpha production. Genes Immun 5: 426-430, 2004.
6. HOHDA S, KIMURA A, SASAOKA T, HAYASHI T, UEDA K, YASUNAMI M, OKABE M, FUKUTA N, KUROSAWA T, IZUMI T: Association study of CD14 polymorphism with myocardial infarction in a Japanese population. Jpn Heart J 44: 613-622, 2003.
7. HUBÁČEK JA, ROTHE G, PIŤHA J, ŠKODOVÁ Z, STANĚK V, POLEDNE R, SCHMITZ G: C(-260)→T polymorphism in the promoter of the CD14 monocyte receptor gene as a risk factor for myocardial infarction. Circulation 99: 3218-3220, 1999.
8. HUBÁČEK JA, ŠKODOVÁ Z, ADÁMKOVÁ V, LÁNSKÁ V, VLASÁKOVÁ Z, POLEDNE R: Association of the -159C→T polymorphism in the CD14 promoter with variations in serum lipoprotein levels in healthy subjects. Blood Coagul Fibrinolysis 15: 365-366, 2004.
9. + monocytes and induces foam cell formation mediated only in part by the class B scavenger-receptor CD36. Arterioscler Thromb Vasc Biol 21: 1004-1010, 2001.
10. KIECHL S, WIEDERMANN CJ, WILLEIT J: Toll-like receptor 4 and atherogenesis. Ann Med 35: 164-171, 2003.
11. KOCH W, KASTRATI A, MEHILLI J, VON BECKERATH N, SCHOMIG A: CD14 gene -159C/T polymorphism is not associated with coronary artery disease and myocardial infarction. Am Heart J 143: 971-976, 2002.
12. KONDO T, OHNO M, SHIMOKATA K, IINO S, INDEN Y, MUROHARA T, HIRAI M: CD14 promoter polymorphism is associated with acute myocardial infarction resulting from insignificant coronary artery stenosis. Heart 89: 931-932, 2003.
13. LEVAN TD, BLOOM JW, BAILEY TJ, KARP CL, HALONEN M, MARTINEZ FD, VERCELLI D: A common single nucleotide polymorphism in the CD14 promoter decreases the affinity of Sp protein binding and enhances transcriptional activity. J Immunol 167: 5838-5844, 2001.
14. LONGOBARDO MT, CEFALU AB, PEZZINO F, NOTO D, EMMANUELE G, BARBAGALLO CM, FIORE B, MONASTERO R, CASTELLO A, MOLINI V, NOTARBARTOLO A, TRAVALIS S, AVERNA MR: The C(-260)>T gene polymorphism in the promoter of the CD14 monocyte receptor gene is not associated with acute myocardial infarction. Clin Exp Med 3: 161-165, 2003.
15. MEILER C, MUHLBAUER M, JOHANN M, HARTMANN A, SCHNABL B, WODARZ N, SCHMITZ G, SCHOLMERICH J, HELLERBRAND C: Different effects of a CD14 gene polymorphism on disease outcome in patients with alcoholic liver disease and chronic hepatitis C infection. World J Gastroenterol 11: 6031-6037, 2005.
16. MORANGE PE, TIRET L, SAUT N, LUC G, ARVEILER D, FERRIERES J, AMOUYEL P, EVANS A, DUCIEMETIERE P, CAMBIEN F, JUHAN-VAGUE I. PRIME STUDY GROUP: TLR4/Asp299Gly, CD14/C-260T, plasma levels of the soluble receptor CD14 and the risk of coronary heart disease: The PRIME Study. Eur J Hum Genet 12: 1041-1049, 2004.
17. MORANGE PE, SAUT N, ALESSI MC, FRERE C, HAWE E, YUDKIN JS, TREMOLI E, MARGAGLIONE M, DI MINNO G, HAMSTEN A, HUMPHRIES SE, JUHAN-VAGUE I; HIFMECH STUDY GROUP: Interaction between the C-260T polymorphism of the CD14 gene and the plasma IL-6 concentration on the risk of myocardial infarction: the HIFMECH study. Atherosclerosis 179: 317-323, 2005.
18. NAUCK M, WINKELMANN BR, HOFFMANN MM, BOHM BO, WIELAND H, MARZ W: C(-260)T polymorphism in the promoter of the CD14 gene is not associated with coronary artery disease and myocardial infarction in the Ludwigshafen Risk and Cardiovascular Health (LURIC) study. Am J Cardiol 90: 1249-1252, 2002.
19. NEWBURGER JW, FULTON DR: Kawasaki disease. Curr Opin Pediatr 16: 508-514, 2004.
20. NISHIMURA S, ZAITSU M, HARA M, YOKOTA G, WATANABE M, UEDA Y, IMAYOSHI M, ISHII E, TASAKI H, HAMASAKI Y: A polymorphism in the promoter of the CD14 gene (CD14/-159) is associated with the development of coronary artery lesions in patients with Kawasaki disease. J Pediatr 143: 357-362, 2003.
21. PORSCH-OEZCUERUEMEZ M, KUNZ D, KLOER HU, LULEY C: Evaluation of serum levels of solubilized adhesion molecules and cytokine receptors in coronary heart disease. J Am Coll Cardiol 34: 1995-2001, 1999.
22. SHIH HH, LIN TM, CHUANG JH, ENG HL, JUO SH, HUANG FC, CHEN CL, CHEN HL: Promoter polymorphism of the CD14 endotoxin receptor gene is associated with biliary atresia and idiopathic neonatal cholestasis. Pediatrics 116: 437-441, 2005.
23. SHIMADA K, WATANABE Y, MOKUNO H, IWAMA Y, DAIDA H, YAMAGUCHI H: Common polymorphism in the promoter of the CD14 monocyte receptor gene is associated with acute myocardial infarction in Japanese men. Am J Cardiol 86: 682-684, 2000.
24. SHIMADA K, MIYAUCHI K, MOKUNO H, WATANABE Y, IWAMA Y, SHIGEKIYO M, MATSUMOTO M, OKAZAKI S, TANIMOTO K, KURATA T, SATO H, DAIDA H: Promoter polymorphism in the CD14 gene and concentration of soluble CD14 in patients with in-stent restenosis after elective coronary stenting. Int J Cardiol 94: 87-92, 2004.
25. UNKELBACH K, GARDEMANN A, KOSTRZEWA M, PHILIPP M, TILLMANNS H, HABERBOSCH W: A new promoter polymorphism in the gene of lipopolysaccharide receptor CD14 is associated with expired myocardial infarction in patients with low atherosclerotic risk profile. Arterioscler Thromb Vasc Biol 19: 932-938, 1999.